Unfair and deceptive acts and practices in the exploitation and sale of foods, drugs, diagnostic and therapeutic devices and cosmetics in interstate and foreign commerce, even though not involved in commercial competition, will shortly come under the jurisdiction of the Federal Trade Commission through the operation of the Wheeler-Lea Act,1 approved March 21 by the President. The act becomes effective on the expiration of sixty days immediately following the date of its approval. The jurisdiction of the Federal Trade Commission over unfair and deceptive acts and practices is now limited to such as constitute or form a part of unfair methods of commercial competition. The act just approved will give the commission, too, specific jurisdiction over the advertising of foods, drugs, diagnostic and therapeutic devices and cosmetics, whenever such advertising is disseminated in interstate and foreign commerce. Advertising that is disseminated or displayed only locally will come within the
WHEELER-LEA BILL GIVING FEDERAL TRADE COMMISSION JURISDICTION OVER FOODS, DRUGS, DEVICES AND COSMETICS BECOMES A LAW. JAMA. 1938;110(14):1112–1113. doi:10.1001/jama.1938.02790140044012
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: